Volume 77, Number 11, September 13, 2011
About this course
- Released: 09/12/2011
- Expires: 09/13/2013
Learning Objectives:
Upon completion of the article by Sixel-Döring et al, the participant should be able to:
• State the definition and probable neuroanatomical substrate of REM sleep behavior disorder (RBD)
• State the percentage of Parkinson disease (PD) patients investigated by polysomnography in this study who were identified to have RBD
• Discuss the findings from this study regarding the factors associated with RBD in PD patients
Core Competencies:
The article by Sixel-Döring et al covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Tan et al, the participant should be able to:
• State the number of MS patients who were reported to develop natalizumab-associated progressive multifocal leukoencephalopathy (PML) from November 2006 to March 2010
• State the definition of natalizumab-associated PML-immune reconstitution inflammatory syndrome (PML-IRIS) as used in this study
• Discuss the clinical features and prognostic factors of patients with natalizumab-associated PML-IRIS as described in this study
Core Competencies:
The article by Tan et al covers the following core competency:
• Medical knowledge
Author Disclosures
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.